Development of α 1,3-galactosyltransferase Inactivated and Human Membrane Cofactor Protein Expressing Homozygous Transgenic Pigs for Xenotransplantation

Abstract

Transplantation is considered to be a very useful approach to improve human welfare and to prolong life-span. Heterologous organ transplantation using pig organs which are similar to human beings and easy to make mass-production has known as one of the alternatives. To ensure potential usage of the pig organ for transplantation application, it is essentially required to generate transgenic pig modifying immuno-related genes. Previously, we reported production of heterozygous α 1,3-galactosyltransferase (GalT) knock-out and human membrane cofactor protein (MCP) expressing pig (GalT -MCP/+ ), which is enforced for suppression of hyperacute and acute immunological rejection. In this study, we reported generation of homozygous pig (GalT -MCP/-MCP ) by crossbreeding GalT -MCP/+ pigs.Two female founders gave birth to six of GalT -MCP/-MCP , and seven GalT -MCP/+ pigs. We performed quantitative real-time PCR, western blot, and flow cytometry analyses to confirm GalT and MCP expression. We showed that fibroblasts of the GalT -MCP/-MCP pig do not express GalT and its product Gal antigen, while efficiently express MCP. We also showed no expression of GalT, otherwise expression of MCP at heart, kidney, liver and pancreas of transgenic pig.Taken together, we suggest that the GalT -MCP/-MCP pig is a useful candidate to apply xenotransplantation study.

Development of PCR based approach to detect potential mosaicism in porcine embryos

“…35, No. 4, December 2020 324 (Ji et al, 2017;Lee et al, 2017;Cho et al, 2018b;Choi and Lee, 2019). During the last 20 years, genetically engineered (GE) pigs have been mainly produced through manipulating genes in the somatic cells, followed by somatic cell nuclear transfer (SCNT) (Dai et al, 2002;Lai et al, 2002;Choi et al, 2017;Jeon and Rho, 2020).…”